Dr. Ascherman's work was supported by the NIH (grant K08-AR-047891); he also is a recipient of a National Arthritis Foundation Investigator award.
Anti–Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy
Article first published online: 30 AUG 2007
Copyright © 2007 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 56, Issue 9, pages 3125–3131, September 2007
How to Cite
Stone, K. B., Oddis, C. V., Fertig, N., Katsumata, Y., Lucas, M., Vogt, M., Domsic, R. and Ascherman, D. P. (2007), Anti–Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis & Rheumatism, 56: 3125–3131. doi: 10.1002/art.22865
- Issue published online: 30 AUG 2007
- Article first published online: 30 AUG 2007
- Manuscript Accepted: 1 JUN 2007
- Manuscript Received: 9 NOV 2006
- NIH. Grant Number: K08-AR-047891
- 1Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193–208., .
- 2Idiopathic inflammatory myopathy. In: WortmannRL, editor. Diseases of skeletal muscle. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 45–86..
- 19Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986; 17: 704–21., .